FORM OF INDEMNIFICATION AGREEMENT GENETRON HOLDINGS LIMITEDIndemnification Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories
This Indemnification Agreement (this “Agreement”), made and entered into as of the day of , 2019, by and between Genetron Holdings Limited, an exempted company with limited liability under the laws of Cayman Islands (the “Company”) and (“Indemnitee”).
Exclusive Business Cooperation AgreementExclusive Business Cooperation Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories
This Exclusive Business Cooperation Agreement (this “Agreement”) is made and entered into by and between the following parties on July 2, 2019 in Beijing, the People’s Republic of China (“China” or the “PRC”).
SHARES PURCHASE AGREEMENTShares Purchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
The Company, the HK Co., the WFOE, the PRC Affiliate and all their direct or indirect subsidiaries are referred to collectively herein as the “Group Companies”, and each a “Group Company”.
Exclusive Option AgreementExclusive Option Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories
This Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties on July 30, 2019 in Beijing, the People’s Republic of China (the “PRC”):
Shareholder Voting Rights Entrustment AgreementShareholder Voting Rights Entrustment Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Beijing
This Shareholder Voting Rights Entrustment Agreement (hereinafter referred to as the “Agreement”) is signed among following Parties on July 30, 2019 in Beijing, the People’s Republic of China (the “PRC”).
Spouse Consent LetterSpouse Consent Letter • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories
Equity Interest Pledge AgreementEquity Interest Pledge Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Beijing
This Equity Interest Pledge Agreement (hereinafter referred to as this “Agreement”) has been executed by and among the following parties on July 30, 2019 in Beijing:
SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
This SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 1, 2019 by and between Genetron Holdings Limited (泛生子基因(控股)有限公司), an exempted company organized and existing under the laws of the Cayman Islands (the “Company”), and EASY BENEFIT INVESTMENT LIMITED, a company organized and existing under the laws of the British Virgin Islands (the “Seller”).
SERIES D PREFERRED SHARES PURCHASE AGREEMENTSeries D Preferred Shares Purchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
Each company as set forth in Table C of Schedule I attached hereto are referred to collectively herein as the “PRC Subsidiaries” and each, a “PRC Subsidiary”. The WFOE, PRC Affiliate, PRC Subsidiaries and all their direct or indirect subsidiaries and branches incorporated in PRC are referred to collectively herein as the “PRC Companies”, and each, a “PRC Company”. The Company, the HK Co. and the PRC Companies are referred to collectively herein as the “Group Companies”, and each a “Group Company”.
SERIES C-2 PREFERRED SHARES PURCHASE AGREEMENTSeries C-2 Preferred Shares Purchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
Each company as set forth in Table C of Schedule I attached hereto are referred to collectively herein as the “PRC Subsidiaries” and each, a “PRC Subsidiary”. The WFOE, PRC Affiliate, PRC Subsidiaries and all their direct or indirect subsidiaries and branches incorporated in PRC are referred to collectively herein as the “PRC Companies”, and each, a “PRC Company”. The Company, the HK Co. and the PRC Companies are referred to collectively herein as the “Group Companies”, and each a “Group Company”.
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • California
This LICENSE AND SUPPLY AGREEMENT (the “Agreement”) is dated and effective January 1, 2018 (the “Effective Date”), by and between Life Technologies Corporation (“LTC”) a Delaware corporation with principal offices at 5781 Van Allen Way, Carlsbad, CA 92008 and Genetron Health (Beijing) Company, Ltd., (“Licensee”), a company incorporated under the laws of the People’s Republic of China with offices at 1-2/F, Building 11, Zone 1, 8 Life Science Parkway, Changping District, Beijing, China. Each of LTC and Licensee will be a “Party” hereto, and together the “Parties”.
SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
This SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 1, 2019 by and between Genetron Holdings Limited (泛生子基因(控股)有限公司), an exempted company organized and existing under the laws of the Cayman Islands (the “Company”), and Parkland Medtech Limited, an exempted company organized and existing under the laws of the Cayman Islands (the “Seller”).
SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
WHEREAS, the Sellers are the shareholders of the Company, which hold certain number of ordinary shares of a par value US$0.00002 each of the Company (the “Ordinary Shares”).
AMENDMENT AGREEMENT TO SERIES C-2 PREFERRED SHARES PURCHASE AGREEMENTSeries C-2 Preferred Shares Purchase Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
THIS AMENDMENT AGREEMENT TO SERIES C-2 PREFERRED SHARES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of November 19, 2019 by and among:
EMPLOYMENT AGREEMENTEmployment Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories
This Employment Agreement (the “Agreement”), dated as of [MONTH DATE], [YEAR] (the “Effective Date”), is entered between Genetron Holdings Limited, a company incorporated in the Cayman Islands (the “Company”) and [NAME] (the “Executive”).
AMENDED AND RESTATED SHAREHOLDERS AGREEMENTShareholder Agreement • November 21st, 2019 • Genetron Holdings LTD • Services-medical laboratories • Hong Kong
The Company, the HK Co., the WFOE, the PRC Affiliate, and the subsidiaries and branches (if any) of each of the foregoing are referred to collectively herein as the “Group Companies”, and each, a “Group Company”. The WFOE, and the PRC Affiliate are referred to collectively herein as the “PRC Companies”, and each a “PRC Company”.
